Citations (66)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Alan L. Myers. (2022) Metabolism of the areca alkaloids – toxic and psychoactive constituents of the areca (betel) nut. Drug Metabolism Reviews 54:4, pages 343-360.
Read now
Read now
Sunny O. Abarikwu, Chidimma J. Mgbudom-Okah, Rex-Clovis C. Njoku, Chinedu J. Okonkwo, Confidence C. Onuoha & Adaba F.S. Wokoma. (2022) Gallic acid ameliorates busulfan-induced testicular toxicity and damage in mature rats. Drug and Chemical Toxicology 45:4, pages 1881-1890.
Read now
Read now
Sunny O. Abarikwu, Chidimma J. Mgbudom-Okah & Chigozie L. Onuah. (2022) The protective effect of rutin against busulfan-induced testicular damage in adult rats. Drug and Chemical Toxicology 45:3, pages 1035-1043.
Read now
Read now
Thaksin Jansing, Kleebsabai Sanpakit, Trai Tharnpanich, Thanjira Jiranantakan, Vachira Niphandwongkorn, Busba Chindavijak & Thanarat Suansanae. (2021) Therapeutic drug monitoring of intravenous busulfan in Thai children undergoing hematopoietic stem cell transplantation: A pilot study. Pediatric Hematology and Oncology 38:4, pages 346-357.
Read now
Read now
Nikhilesh V. Dhuria, Bianka Haro, Amit Kapadia, Khadjia A. Lobo, Bernice Matusow, Mary A. Schleiff, Christina Tantoy & Jasleen K. Sodhi. (2021) Recent developments in predicting CYP-independent metabolism. Drug Metabolism Reviews 53:2, pages 188-206.
Read now
Read now
Articles from other publishers (61)
Alison M. Gulbis & Whitney D. Wallis. 2024. Manual of Hematopoietic Cell Transplantation and Cellular Therapies. Manual of Hematopoietic Cell Transplantation and Cellular Therapies
125
143
.
Şule Camcıoğlu, Baran Özyurt, Nihal Oturan, David Portehault, Clément Trellu & Mehmet A. Oturan. (2023) Heterogeneous electro-Fenton treatment of chemotherapeutic drug busulfan using magnetic nanocomposites as catalyst. Chemosphere 341, pages 140129.
Crossref
Crossref
Brooke Langevin, Jogarao V.S. Gobburu & Mathangi Gopalakrishnan. (2023) Is There a Need for a Dedicated Pharmacokinetic Trial for a Drug in Obese Populations? A Drug Prioritization Decision Tree Framework. The Journal of Clinical Pharmacology 63:S2.
Crossref
Crossref
Julien Allard, Simon Bucher, Pierre‐Jean Ferron, Youenn Launay & Bernard Fromenty. (2023) Busulfan induces steatosis in HepaRG cells but not in primary human hepatocytes: Possible explanations and implication for the prediction of drug‐induced liver injury. Fundamental & Clinical Pharmacology.
Crossref
Crossref
Takuto Takahashi, Masahiro Teramoto, Kana Matsumoto, Mutaz M. Jaber, Hiroya Tamaki, Kazuhiro Ikegame, Satoshi Yoshihara & Katsuji Kaida. (2023) Population Pharmacokinetics of Total Rabbit Anti-thymocyte Globulin in Non-obese Adult Patients Undergoing Hematopoietic Cell Transplantation for Hematologic Malignancy. Clinical Pharmacokinetics 62:8, pages 1081-1091.
Crossref
Crossref
T. Bognàr, J. S. Kingma, E. H. Smeijsters, K. C. M. van der Elst, C. T. M. de Kanter, C. A. Lindemans, A. C. G. Egberts, I. H. Bartelink & A. Lalmohamed. (2023) Busulfan target exposure attainment in children undergoing allogeneic hematopoietic cell transplantation: a single day versus a multiday therapeutic drug monitoring regimen. Bone Marrow Transplantation 58:7, pages 762-768.
Crossref
Crossref
Sarah A. Morris, D. Grace Nguyen & Jai N. Patel. (2023) Pharmacogenomics in allogeneic hematopoietic stem cell transplantation: Implications on supportive therapies and conditioning regimens. Best Practice & Research Clinical Haematology 36:2, pages 101470.
Crossref
Crossref
Cristina Ballesteros, Karen Wong, Maia Araujo Abrahim, Christian Li & Simon Authier. (2022) Model Characterization: Total Body Irradiation or Busulfan for Conditioning in Human Cell Therapy Toxicology and Tumorigenicity Studies using NOD/SCID/IL2Rγnull (NSG) Mice. International Journal of Toxicology 42:3, pages 219-231.
Crossref
Crossref
Rolf Teschke. (2023) Molecular Idiosyncratic Toxicology of Drugs in the Human Liver Compared with Animals: Basic Considerations. International Journal of Molecular Sciences 24:7, pages 6663.
Crossref
Crossref
Mohammad Ebad Ur Rehman, Asmi Chattaraj, Anber Mahboob, Zarnab Ijaz, Diana Franco, Muhammad Farhan, Kuldeep Dharma, Hassan Mumtaz, Sajeel Saeed, Jawad Basit, Muhammad Muaaz Aslam, Ahmad Iftikhar, Fatima Faraz & Faiz Anwer. (2023) Total Body Irradiation Versus Chemotherapy Conditioning in Pediatric Acute Lymphoblastic Leukemia Patients Undergoing Hematopoietic Stem Cell Transplant: A Systematic Review and Meta-Analysis. Clinical Lymphoma Myeloma and Leukemia 23:4, pages 249-258.
Crossref
Crossref
Valeria Guidolin, Yupeng Li, Foster C. Jacobs, Margaret L. MacMillan, Peter W. Villalta, Stephen S. Hecht & Silvia Balbo. (2023) Characterization and quantitation of busulfan DNA adducts in the blood of patients receiving busulfan therapy. Molecular Therapy - Oncolytics 28, pages 197-210.
Crossref
Crossref
Jasmine Canlas & Alan L. Myers. (2023) Interactions of Betel Quid Constituents with Drug Disposition Pathways: An
Overview. Current Drug Metabolism 24:2, pages 92-105.
Crossref
Crossref
Bashayer F. Al-Enezi, Nada Al-Hasawi & Kamal M. Matar. (2023) Impact of valproic acid on busulfan pharmacokinetics: In vitro assessment of potential drug-drug interaction. PLOS ONE 18:1, pages e0280574.
Crossref
Crossref
Hiroko MORIMOTO, Mito KANATSU-SHINOHARA & Takashi SHINOHARA. (2023) WIN18,446 enhances spermatogonial stem cell homing and fertility after germ cell transplantation by increasing blood-testis barrier permeability. Journal of Reproduction and Development 69:6, pages 347-355.
Crossref
Crossref
Pattanaik Smita, Patil Amol Narayan, Kumaravel J & Prakash Gaurav. (2022) Therapeutic drug monitoring for cytotoxic anticancer drugs: Principles and evidence-based practices. Frontiers in Oncology 12.
Crossref
Crossref
Shannon Robin, Khalil Ben Hassine, Jayaraman Muthukumaran, Simona Jurkovic Mlakar, Maja Krajinovic, Tiago Nava, Chakradhara Rao S. Uppugunduri & Marc Ansari. (2022) A potential implication of UDP-glucuronosyltransferase 2B10 in the detoxification of drugs used in pediatric hematopoietic stem cell transplantation setting: an in silico investigation. BMC Molecular and Cell Biology 23:1.
Crossref
Crossref
Stephen H. Curry & Robin Whelpton. 2022. Drug Disposition and Pharmacokinetics. Drug Disposition and Pharmacokinetics
275
302
.
Ashwin Kamath, Suresh Kumar Srinivasamurthy, Mukta N. Chowta, Sheetal D. Ullal, Youssef Daali & Uppugunduri S. Chakradhara Rao. (2022) Role of Drug Transporters in Elucidating Inter-Individual Variability in Pediatric Chemotherapy-Related Toxicities and Response. Pharmaceuticals 15:8, pages 990.
Crossref
Crossref
Tareq ArtulIsrael Henig, Laila NassarDana Yehudai-Ofir, Inna ScherbYael LurieEdna EfratiTsila ZuckermanDaniel Kurnik. (2022) Decreased Systemic Busulfan Exposure After Oral Dosing With Concomitant Levetiracetam Compared With Phenytoin. Therapeutic Drug Monitoring 44:3, pages 414-418.
Crossref
Crossref
Claire Seydoux, Raphael Battegay, Joerg Halter, Dominik Heim, Katharina M. Rentsch, Jakob R. Passweg & Michael Medinger. (2022) Impact of busulfan pharmacokinetics on outcome in adult patients receiving an allogeneic hematopoietic cell transplantation. Bone Marrow Transplantation 57:6, pages 903-910.
Crossref
Crossref
Allison Dunn, Brady S. Moffett, Vijay Ivaturi & Jogarao V. S. Gobburu. (2021) Characterization of drug–drug interactions on the pharmacokinetic disposition of busulfan in paediatric patients during haematopoietic stem cell transplantation conditioning. British Journal of Clinical Pharmacology 88:5, pages 2223-2235.
Crossref
Crossref
Stephan Schaller, Frederico S. Martins, Pavel Balazki, Sonja Böhm, Joachim Baumgart, Ralf A. Hilger, Dietrich W. Beelen, Claudia Hemmelmann & Arne Ring. (2021) Evaluation of the drug‐drug interaction potential of treosulfan using a physiologically‐based pharmacokinetic modelling approach. British Journal of Clinical Pharmacology 88:4, pages 1722-1734.
Crossref
Crossref
Alan L. Myers. (2022) VOD/SOS and Alkylating Agents in the Hematopoietic Stem Cell Transplant Setting: New Insights and Further Questions. Transplantation and Cellular Therapy 28:4, pages 179-180.
Crossref
Crossref
Tim Bognàr, Imke H. Bartelink, Toine C.G. Egberts, Carin M.A. Rademaker, A. Birgitta Versluys, Mary A. Slatter, Morris Kletzel, Christa E. Nath, Geoffrey D.E Cuvelier, Rada M. Savic, Christopher Dvorak, Janel R. Long-Boyle, Morton J. Cowan, Henrique Bittencourt, Robbert G.M. Bredius, Tayfun Güngör, Peter J. Shaw, Marc Ansari, Moustapha Hassan, Maja Krajinovic, Georg Hempel, Sarah Marktel, Robert Chiesa, Yves Théoret, Troy Lund, Paul J. Orchard, Robert F. Wynn, Jaap Jan Boelens & Arief Lalmohamed. (2022) Association Between the Magnitude of Intravenous Busulfan Exposure and Development of Hepatic Veno-Occlusive Disease in Children and Young Adults Undergoing Myeloablative Allogeneic Hematopoietic Cell Transplantation. Transplantation and Cellular Therapy 28:4, pages 196-202.
Crossref
Crossref
Daniel L. Lourenço & Ana C. Fernandes. (2022) Depolymerization of P4HB and PBS Waste and Synthesis of the Anticancer Drug Busulfan from Plastic Waste. Catalysts 12:4, pages 381.
Crossref
Crossref
Ai-Hoc Nguyen, Mohitosh Biswas, Apichaya Puangpetch, Santirhat Prommas, Samart Pakakasama, Usanarat Anurathapan, Jiratha Rachanakul, Rattanaporn Sukprasong, Nutthan Nuntharadtanaphong, Nutcha Jongjitsook, Suradej Hongeng & Chonlaphat Sukasem. (2022) Effect of GSTA1 Variants on Busulfan-Based Conditioning Regimen Prior to Allogenic Hematopoietic Stem-Cell Transplantation in Pediatric Asians. Pharmaceutics 14:2, pages 401.
Crossref
Crossref
Takuto Takahashi, Sílvia M. Illamola, Cathryn A. Jennissen, Susan E. Long, Troy C. Lund, Paul J. Orchard, Ashish O. Gupta & Janel R. Long-Boyle. (2022) Busulfan dose Recommendation in Inherited Metabolic Disorders: Population Pharmacokinetic Analysis. Transplantation and Cellular Therapy 28:2, pages 104.e1-104.e7.
Crossref
Crossref
Sonja Essmann, Adrin Dadkhah, Dietlinde Janson, Christine Wolschke, Francis Ayuk, Nicolaus M Kröger & Claudia Langebrake. (2022) Iron Chelation With Deferasirox Increases Busulfan AUC During Conditioning Chemotherapy Prior to Allogeneic Stem Cell Transplantation. Transplantation and Cellular Therapy 28:2, pages 115.e1-115.e5.
Crossref
Crossref
R. Scott Obach & Nina Isoherranen. 2022. Atkinson's Principles of Clinical Pharmacology. Atkinson's Principles of Clinical Pharmacology
151
168
.
Simona Jurkovic Mlakar, Satyanarayana Chakradhara Rao Uppugunduri, Tiago Nava, Vid Mlakar, Hadrien Golay, Shannon Robin, Nicolas Waespe, Mohamed Aziz Rezgui, Yves Chalandon, Jaap Jan Boelens, Robert G. M. Bredius, Jean-Hugues Dalle, Christina Peters, Selim Corbacioglu, Henrique Bittencourt, Maja Krajinovic & Marc Ansari. (2021) GSTM1 and GSTT1 double null genotypes determining cell fate and proliferation as potential risk factors of relapse in children with hematological malignancies after hematopoietic stem cell transplantation. Journal of Cancer Research and Clinical Oncology 148:1, pages 71-86.
Crossref
Crossref
Fumiko Takahashi Ito, Cintia Vecchies Morassi, Gabriela Sandoval da Silva, Larissa Zuppardi Lacerda Sabino & Mariana Perez Esteves Silva Motta. 2022. The Golden Guide to Oncologic Pharmacy. The Golden Guide to Oncologic Pharmacy
437
471
.
Jean Hagenburg, Laurent Savale, Benoit Lechartier, Maria‐Rosa Ghigna, Marie‐Camille Chaumais, Xavier Jaïs, Olivier Sitbon, Marc Humbert & David Montani. (2021) Pulmonary hypertension associated with busulfan. Pulmonary Circulation 11:4, pages 1-12.
Crossref
Crossref
Takuto Takahashi, Aileen Scheibner, Qing Cao, Rachael Pearson, Kinjal Sanghavi, Daniel J. Weisdorf, Claudio G. Brunstein, John Rogosheske, Veronika Bachanova, Erica D. Warlick, Anthony Wiseman & Pamala A. Jacobson. (2021) Higher Fludarabine and Cyclophosphamide Exposures Lead to Worse Outcomes in Reduced-Intensity Conditioning Hematopoietic Cell Transplantation for Adult Hematologic Malignancy. Transplantation and Cellular Therapy 27:9, pages 773.e1-773.e8.
Crossref
Crossref
Khalil Ben Hassine, Tiago Nava, Yves Théoret, Christa E. Nath, Youssef Daali, Nastya Kassir, Victor Lewis, Robbert G. M. Bredius, Peter J. Shaw, Henrique Bittencourt, Maja Krajinovic, Chakradhara Rao Satyanarayana Uppugunduri & Marc Ansari. (2021) Precision dosing of intravenous busulfan in pediatric hematopoietic stem cell transplantation: Results from a multicenter population pharmacokinetic study. CPT: Pharmacometrics & Systems Pharmacology 10:9, pages 1043-1056.
Crossref
Crossref
Amandine Remy, Yves Théorêt, Marc Ansari, Henrique Bittencourt, Thierry Ducruet, Tiago Nava, Yves Pastore, Mohamed A. Rezgui, Maja Krajinovic & Niina Kleiber. (2021) Is Busulfan Clearance Different in Patients With Sickle Cell Disease? Let’s Clear Up That Case With Some Controls. Journal of Pediatric Hematology/Oncology 43:6, pages e867-e872.
Crossref
Crossref
Turgay Cokyaman, Murat Elli, Ömer F. Aydin, Canan Albayrak, Davut Albayrak & Emel Özyürek. (2020) Neuroprotective Efficacy of Prophylactic Antiepileptic Therapies in Busulfan Conditioning Regimen. Journal of Pediatric Neurology 19:04, pages 235-239.
Crossref
Crossref
Hiroko Morimoto, Narumi Ogonuki, Mito Kanatsu-Shinohara, Shogo Matoba, Atsuo Ogura & Takashi Shinohara. (2021) Spermatogonial stem cell transplantation into nonablated mouse recipient testes. Stem Cell Reports 16:7, pages 1832-1844.
Crossref
Crossref
Rong-Long Chen, Li-Hua Fang, Xin-Yi Yang, Mohsin El Amrani, Esther Veronique Uijtendaal, Yen-Fu Chen & Wei-Chi Ku. (2021) Therapeutic Drug Monitoring of Busulfan in Patients Undergoing Hematopoietic Cell Transplantation: A Pilot Single-Center Study in Taiwan. Pharmaceuticals 14:7, pages 613.
Crossref
Crossref
Chenxia Hao, Xiaoqin Ma, Lining Wang, Weixia Zhang, Jiong Hu, Jingjing Huang & Wanhua Yang. (2020) Predicting the presence and mechanism of busulfan drug-drug interactions in hematopoietic stem cell transplantation using pharmacokinetic interaction network–based molecular structure similarity and network pharmacology. European Journal of Clinical Pharmacology 77:4, pages 595-605.
Crossref
Crossref
Deepak Kukkar, Preeti Kukkar, Vanish Kumar, Jongki Hong, Ki-Hyun Kim & Akash Deep. (2021) Recent advances in nanoscale materials for antibody-based cancer theranostics. Biosensors and Bioelectronics 173, pages 112787.
Crossref
Crossref
Scott Raskin & Anne L. Angiolillo. 2021. Biochemical and Molecular Basis of Pediatric Disease. Biochemical and Molecular Basis of Pediatric Disease
635
690
.
Rachael Lawson, Christine E. Staatz, Christopher J. Fraser & Stefanie Hennig. (2020) Review of the Pharmacokinetics and Pharmacodynamics of Intravenous Busulfan in Paediatric Patients. Clinical Pharmacokinetics 60:1, pages 17-51.
Crossref
Crossref
Jingjing Huang, Chenxia Hao, Ziwei Li, Ling Wang, Jieling Jiang, Wei Tang, Lining Wang, Weixia Zhang, Jiong Hu & Wanhua Yang. (2020) NRF2 -617 C/A Polymorphism Impacts Proinflammatory Cytokine Levels, Survival, and Transplant-Related Mortality After Hematopoietic Stem Cell Transplantation in Adult Patients Receiving Busulfan-Based Conditioning Regimens. Frontiers in Pharmacology 11.
Crossref
Crossref
Stephanie Hoang, Nhu Dao & Alan L. Myers. (2020) Electrophilic reactivity of the Busulfan metabolite, EdAG, towards cellular thiols and inhibition of human thioredoxin-1. Biochemical and Biophysical Research Communications 533:3, pages 325-331.
Crossref
Crossref
Vianney Poinsignon, Laura Faivre, Laurent Nguyen, Benedicte Neven, Sophie Broutin, Despina Moshous, Philippe Bourget, Christelle Dufour, Jean‐Hugues Dalle, Claire Galambrun, Benedicte Devictor, Veronique Kemmel, Eva De Berranger, Virginie Gandemer, Jean Pierre Vannier, Charlotte Jubert, Sabrina Bondu, Olivier Mir, Aurelie Petain, Gilles Vassal & Angelo Paci. (2020) New dosing nomogram and population pharmacokinetic model for young and very young children receiving busulfan for hematopoietic stem cell transplantation conditioning. Pediatric Blood & Cancer 67:10.
Crossref
Crossref
Emma C. Bernsen, Melanie M. Hagleitner, Theodorus W. Kouwenberg & Lidwien M. Hanff. (2020) Pharmacogenomics as a Tool to Limit Acute and Long-Term Adverse Effects of Chemotherapeutics: An Update in Pediatric Oncology. Frontiers in Pharmacology 11.
Crossref
Crossref
Samantha M. Ervin & Matthew R. Redinbo. (2020) The Gut Microbiota Impact Cancer Etiology through “Phase IV Metabolism” of Xenobiotics and Endobiotics. Cancer Prevention Research 13:8, pages 635-642.
Crossref
Crossref
Jurgen B. Langenhorst, Jill Boss, Charlotte van Kesteren, Arief Lalmohamed, Jürgen Kuball, Antoine C. G. Egberts, Jaap Jan Boelens, Alwin D. R. Huitema & Erik M. van Maarseveen. (2020) A semi‐mechanistic model based on glutathione depletion to describe intra‐individual reduction in busulfan clearance. British Journal of Clinical Pharmacology 86:8, pages 1499-1509.
Crossref
Crossref
Hanen Marsit, Michaël Philippe, Michael Neely, Teresa Rushing, Yves Bertrand, Michel Ducher, Vincent Leclerc, Jérôme Guitton, Nathalie Bleyzac & Sylvain Goutelle. (2020) Intra-individual Pharmacokinetic Variability of Intravenous Busulfan in Hematopoietic Stem Cell-Transplanted Children. Clinical Pharmacokinetics 59:8, pages 1049-1061.
Crossref
Crossref
Kenji Kishimoto, Daiichiro Hasegawa, Kei Irie, Akira Okada, Sayaka Nakamura, Akihiro Tamura, Nobuyuki Yamamoto, Aiko Kozaki, Atsuro Saito, Toshiaki Ishida, Shoji Fukushima & Yoshiyuki Kosaka. (2020) Pharmacokinetic analysis for model‐supported therapeutic drug monitoring of busulfan in Japanese pediatric hematopoietic stem cell transplantation recipients. Pediatric Transplantation 24:4.
Crossref
Crossref
Matthias FelberColin G. StewardKarim KentoucheAnders Fasth, Robert F. WynnUlrike ZeilhoferVeronika HaunerdingerBenjamin Volkmer, Seraina PraderBernd Gruhn, Stephan Ehl, Kai LehmbergDaniel MüllerAndrew R. Gennery, Michael H. AlbertFabian Hauck, Kanchan RaoPaul VeysMoustapha Hassan, Arjan C. Lankester, Jana Pachlopnik SchmidMathias M. Hauri-HohlTayfun Güngör. (2020) Targeted busulfan-based reduced-intensity conditioning and HLA-matched HSCT cure hemophagocytic lymphohistiocytosis. Blood Advances 4:9, pages 1998-2010.
Crossref
Crossref
Abraham S. KanateMiguel-Angel Perales & Mehdi Hamadani. (2020) Eligibility Criteria for Patients Undergoing Allogeneic Hematopoietic Cell Transplantation. Journal of the National Comprehensive Cancer Network 18:5, pages 635-643.
Crossref
Crossref
Abdullah Alsultan, Ahmed A. Albassam, Abdullah Alturki, Abdulrahman Alsultan, Mohammed Essa, Bader Almuzzaini & Salman Alfadhel. (2020) Population pharmacokinetics of busulfan in Saudi pediatric patients undergoing hematopoietic stem cell transplantation. International Journal of Clinical Pharmacy 42:2, pages 703-712.
Crossref
Crossref
Ali Olfati, G. Moghaddam & B. Baradaran. (2019) FSH and estradiol benzoate administration recover spermatogenesis and sexual hormone levels in a busulfan-injured rat model. Comparative Clinical Pathology 29:1, pages 53-59.
Crossref
Crossref
Amitava Dasgupta & Matthew D. Krasowski. 2020. Therapeutic Drug Monitoring Data. Therapeutic Drug Monitoring Data
331
350
.
Michał Romański & Franciszek K. Główka. (2019) In Vitro Study of the Enzymatic and Nonenzymatic Conjugation of Treosulfan with Glutathione. European Journal of Drug Metabolism and Pharmacokinetics 44:5, pages 653-657.
Crossref
Crossref
Eisei Kondo, Takashi Ikeda, Hiroaki Goto, Momoko Nishikori, Naoko Maeda, Kimikazu Matsumoto, Hideo Kitagawa, Naoto Noda, Saori Sugimoto & Junichi Hara. (2019) Pharmacokinetics of thiotepa in high-dose regimens for autologous hematopoietic stem cell transplant in Japanese patients with pediatric tumors or adult lymphoma. Cancer Chemotherapy and Pharmacology 84:4, pages 849-860.
Crossref
Crossref
Takuro Nishikawa, Hiroki Yamaguchi, Kazuro Ikawa, Kazutaka Nakayama, Erika Higashi, Emiko Miyahara, Takanari Abematsu, Shunsuke Nakagawa, Yuichi Kodama, Takayuki Tanabe, Akari Shigemi, Yuichi Shinkoda, Yasuhiro Okamoto, Yasuo Takeda & Yoshifumi Kawano. (2019)
Influence of
GST
polymorphisms on busulfan pharmacokinetics in Japanese children
. Pediatrics International.
Crossref
Crossref
Georg Hempel. 2020. Pediatric Pharmacotherapy. Pediatric Pharmacotherapy
415
440
.
Mohamad Mohty & Florent Malard. (2018) Reply to J.J. Boelens et al. Journal of Clinical Oncology 36:11, pages 1177-1178.
Crossref
Crossref
Kristina M. Brooks, Paul Jarosinski, Thomas Hughes, Elizabeth Kang, Nirali N. Shah, John B. Le Gall, Dennis D. Hickstein, Suk See De Ravin, Jomy M. George & Parag Kumar. (2017) Test Dose Pharmacokinetics in Pediatric Patients Receiving Once‐Daily IV Busulfan Conditioning for Hematopoietic Stem Cell Transplant: A Reliable Approach?. The Journal of Clinical Pharmacology 58:3, pages 332-339.
Crossref
Crossref